Endpoints  JPM 2020 The art of the biotech deal
Channel: OSR TV
Date: 07/01/2021

2020년 1월 진행된 JPM conference 중 바이오텍 Dealmaking을 주제로한 패널토의 세션입니다.

참여 패널:
Marianne De Backer, EVP Global head business development & licensing, Bayer
Arie Belldegrun, Allogene Therapeutics, Executive Chairman & CoFounder 
Stéphane Bancel, CEO&FOUNDER, Moderna Therapeutics
Vivek Ramaswamy, CEO&FOUNDER, Roivant Sciences
Josh Bilenker, CEO, ALLOGENE (fomer CEO of Loxo Oncology by Eli Lilly).


출 처:
https://endpts.com/video-replay-endpoints-at-jpm20-newsmakers-on-dealmaking-pricing-and-manufacturing/